Deutsche Bank Aktiengesellschaft »

Apogee Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 21k 58.74
2024-06-30 $637k 16k 39.35
2024-03-31 $1.3M 19k 66.45
2023-12-31 $214k 7.7k 27.94
2023-09-30 $98k 4.6k 21.30